Yazar "Asan, Ali" için listeleme
-
Changes in antimicrobial resistance and outcomes of health care–associated infections
Aydın, Mehtap; Azak, Emel; Bilgin, Hüseyin; Menekşe, Şirin; Asan, Ali; Elmaslar Mert, Habibe Tülin; Yuluğkural, Zerrin; Altunal, Lütfiye Nilsun; Ataman Hatipoğlu, Çiğdem; Tuncer Ertem, Günay; Sargın Altunok, Elif; Demirkaya, Melike Hamiyet; Alkan Çeviker, Sevil; Akgül, Fethiye; Memiş, Zeynep; Konya, Petek; Azap, Alpay; Aydın, Güle; Korkmaz, Derya; Karakoç, Zehra Çağla; Yapar, Derya; Karakeçili, Faruk; Günal, Özgür; Keske, Şiran; Kapmaz, Mahir; Kader, Çiğdem; Demirel, Aslıhan; Ergönül, Önder (Springer, 14.02.2021)To describe the change in the epidemiology of health care–associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate ... -
Impact of the COVID-19 pandemic on surgical site infections: a multi-center study evaluating incidence, pathogen distribution, and antimicrobial resistance patterns
Keske, Siran; Altunok, Elif Sargin; Azak, Emel; Gulten, Ezgi; Gulen, Tugba Arslan; Hatipoglu, Cigdem Ataman; Asan, Ali (Bmc, 2025)BackgroundSurgical site infections (SSIs) are among the most significant concerns in healthcare settings, presenting challenges in patient management and healthcare outcomes. The emergence of the COVID-19 pandemic has ... -
Management of Chronic Hepatitis B Infection: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023 Update
Demirturk, Nese; Kose, Adem; Ural, Onur; Asan, Ali; Barut, Sener; Sumer, Sua; Simsek, Funda (Doc Design Informatics Co Ltd, 2023)The consensus report on the management of chronic hepatitis B (CHB) was first published in 2014 by the Viral Hepatitis Study Group of the Turkish Society of Clinical Microbiology and Infectious Diseases. The need for ... -
New Treatment Options in Chronic Hepatitis B: How Close Are We to Cure?
Korkmaz, Pinar; Asan, Ali; Karakecili, Faruk; Tekin, Sueda; Demirturk, Nese (Doc Design Informatics Co Ltd, 2023)Hepatitis B virus (HBV) infection is the leading cause of chronic liver disease worldwide. HBV-infected patients are at a lifetime risk of developing liver cirrhosis and hepatocellular carcinoma (HCC). Today, pegylated ... -
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
Demirtürk, Neşe; Aygen, Bilgehan; Çelik, İlhami; Mistik, Reşit; Akhan, Sıla; Barut, Şener; Ural, Onur; Batırel, Ayşe; Şimşek, Funda; Ersöz, Gülden; İnan, Dilara; Kınıklı, Sami; Türker, Nesrin; Bilgin, Hüseyin; Gürbüz, Yunus; Tülek, Necla; Tarakçı, Hüseyin; Yıldız, Orhan; Türkoğlu, Emine; Kamalak Güzel, Deniz; Şimşek, Sümeyra; Tuna, Nazan; Aktuğ Demir, Nazlım; Çağatay, Atahan; Çetinkaya, Rıza Aytaç; Karakeçili, Faruk; Hakyemez, İsmail Necati; Ertem, Günay Tuncer; Örmen, Bahar; Korkmaz, Pınar; Sili, Uluhan; Kuruüzüm, Ziya; Şener, Alper; Özel, Selcan Arslan; Öztürk, Sinan; Süer, Kaya; Çelen, Mustafa Kemal; Konya, Petek; Asan, Ali; Saltoğlu, Neşe; Doğan, Nurhan (AVES Yayıncılık, 2021)Background: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice. Methods: Data from patients with chronic ...
